Free Trial

Trevi Therapeutics (TRVI) SEC Filings & 10K Form

Trevi Therapeutics logo
$2.94
-0.12 (-3.92%)
(As of 10/31/2024 ET)

Recent Trevi Therapeutics SEC Filings

DateFilerForm TypeView
10/23/2024
1:44 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
10/21/2024
9:43 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:07 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:00 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:54 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:37 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:55 PM
Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:10 PM
Meeker David P (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
4:14 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Subject)
Form 144/A
07/11/2024
4:52 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
07/10/2024
3:16 PM
MAI Capital Management (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
06/14/2024
3:40 PM
Mathers Edward T (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Colangelo Dominick (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Trevi Therapeutics (Issuer)
VANLENT ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Heffernan Michael Thomas (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Cassella James V (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
5:34 PM
New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13D/A
05/14/2024
3:51 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:09 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
6:39 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
03/20/2024
3:08 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:10 PM
Trevi Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2024
3:12 PM
Trevi Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/16/2024
3:42 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:43 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:43 PM
Clark David J (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:43 PM
Simon Farrell (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:44 PM
Galletta Christopher (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:42 PM
Delfini Lisa (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:47 PM
Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
02/14/2024
2:48 PM
Fairmount Funds Management LLC (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
02/14/2024
9:21 AM
Trevi Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/12/2024
5:06 AM
Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRVI) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners